1.49
1.49 (0%)
As of Feb 14, 2025
Ikena Oncology, Inc. [IKNA]
Source:
Company Overview
Ikena Oncology, Inc. have historically been a clinical stage, targeted oncology company, focused on developing differentiated therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance. Our approach has been to target both cancer-driving targets and mechanisms of resistance to other therapies.
Country | United States |
Headquarters | boston, massachusetts |
Phone Number | 857-343-8292 |
Industry | |
CEO | Mark Manfredi, Ph.D. |
Website | www.clinicaltrials.gov |